Early and late antibody mediated rejection: Which game is the complement playing?

Area of Science:

• Nephrology
• Immunology
• Transplantation

Background:

• The complement system plays a role in antibody-mediated rejection (AMR) after kidney transplantation.
• Complement fragments in biopsies confirm AMR, but antibody-driven injury can occur without complement activation.
• Complement-independent mechanisms may be more significant in late AMR (>6 months post-transplant).

Purpose of the Study:

• To review evidence on the differential role of complement activation in early versus late AMR.
• To explore how different donor-specific antibodies (DSA) and complement inhibitors influence AMR.
• To highlight the convergence of late AMR and C4d-negative AMR features.

Main Methods:

• Literature review analyzing diagnostic signs of AMR.
• Examination of C4d staining prevalence over time post-transplantation.
• Analysis of differential responses to anti-complement therapies.
• Assessment of direct and indirect indicators of complement system activation.

Main Results:

• Evidence suggests lower complement activation in late AMR compared to early AMR.
• Downregulation of complement inhibitors post-transplantation may favor early complement activation.
• Clinical and histological features of late AMR and C4d-negative AMR show similarities.

Conclusions:

• Therapeutic strategies for AMR should consider the time-dependent differences in underlying pathophysiological mechanisms.
• Distinguishing between early and late AMR is essential for optimizing treatment.
• Complement activation patterns vary significantly between early and late antibody-mediated rejection.